amongPurchase Agreement • November 13th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
Pledgor has, on this date, executed and delivered to Pledgees or their assigns a promissory note dated the date hereof in the principal amount of Two Hundred Seventy Nine Million Four Hundred Seventeen Thousand and Nine Hundred Eighty- two Dollars...Pledge Agreement • January 18th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
a) At the signing of the Definitive Agreement (the "Signing"), Immunex shall pay Greenwich/AHPC fifty percent (50%) of any Facility Costs incurred after September 24, 1999 and through the end of the calendar quarter just prior to the Signing. Within a...Asset Purchase Agreement • August 30th, 2000 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
Exhibit 10.30 SEVERANCE AGREEMENT ------------------- THIS AGREEMENT, dated as of December 16, 2001, is made by and between Immunex Corporation, a Washington corporation (the "Company"), and Peggy V. Phillips (the "Executive"). WHEREAS, the Company...Severance Agreement • March 8th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Washington
Exhibit 10.2 IMMUNEX CORPORATION FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • August 11th, 2000 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Washington
Common Stock (par value $0.01 per share)Immunex Corp /De/ • November 15th, 2000 • Biological products, (no disgnostic substances) • New York
BY AND AMONG AMGEN INC.,Agreement and Plan of Merger • December 17th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Delaware
RECITALSEmployment Agreement • March 18th, 1996 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Washington
EXHIBIT 10.3 Secured Promissory Note -----------------------Immunex Corp /De/ • January 18th, 2002 • Biological products, (no disgnostic substances)
AMENDMENT NO. 1 TO PURCHASE AGREEMENTPurchase Agreement • January 18th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
GUARANTEE dated as of March 2, 2001 (this "Guarantee") made by IMMUNEX --------- CORPORATION, a Washington corporation ("Immunex") and IMMUNEX MANUFACTURING ------- CORPORATION, a Washington corporation (together with Immunex, individually and...Guarantee • March 5th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
LEASE between IMMUNEX REAL ESTATE TRUST 2001, as Lessor, and IMMUNEX CORPORATION, as LesseeLease • March 5th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
AMENDMENT NO. 2 to AMENDED AND RESTATED GOVERNANCE AGREEMENTGovernance Agreement • August 10th, 2000 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
ARTICLE II VOTING AGREEMENT AND IRREVOCABLE PROXYShareholder Voting Agreement • December 17th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Delaware
FOURTH AMENDMENT TO REAL ESTATE PURCHASE AND SALE AGREEMENTReal Estate Purchase and Sale Agreement • March 23rd, 1998 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
THE NOTE EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT...Immunex Corp /De/ • May 28th, 1999 • Biological products, (no disgnostic substances)
THE NOTE EVIDENCED HEREBY HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS THAT (A) IT IS A "QUALIFIED INSTITUTIONAL BUYER" (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) OR (B) IT IS AN INSTITUTIONAL "ACCREDITED INVESTOR" (AS DEFINED IN RULE 501(A)(1), (2), (3) OR (7) UNDER THE SECURITIES ACT) ("INSTITUTIONAL ACCREDITED INVESTOR"); (2) AGREES THAT IT WILL NOT, PRIOR TO EXPIRATION OF THE HOLDING PERIOD APPLICABLE TO SALES OF THE NOTE EVIDENCED HEREBY UNDER RULE 144 UNDER THE SECURITIES ACT (OR ANY SUCCESSOR PROVISION), RESELL OR OTHERWISE TRANSFER THE NOTE EVIDENCED HEREBY OR THE COMMON STOCK ISSUABLE UPON CONVERSION OF SUCH NOTE EXCEPT (A) TO IMMUNEX CORPORATION OR ANY SUBSIDIARY THE
2. Term of Agreement. The Term of this Agreement shall commence on the ----------------- date hereof and shall continue in effect through December 31, 2004; provided, -------- however, that commencing on January 1, 2002 and each January 1 thereafter,...Severance Agreement • March 8th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Washington
MARTIN SELIG REAL ESTATE 1000 SECOND AVENUE OFFICE LEASEImmunex Corp /De/ • March 23rd, 1998 • Biological products, (no disgnostic substances) • Washington
AGREEMENT ---------Enbrel Supply Agreement • May 7th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
IMMUNEX CORPORATION 3% CONVERTIBLE SUBORDINATED NOTE DUE 2006 NOTE PURCHASE AGREEMENT DATED AS OF MAY 20, 1999 IMMUNEX CORPORATION 51 UNIVERSITY STREET SEATTLE, WASHINGTON 98101Note Purchase Agreement • May 28th, 1999 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
Exhibit 10.31 SEVERANCE AGREEMENT ------------------- THIS AGREEMENT, dated as of December 16, 2001, is made by and between Immunex Corporation, a Washington corporation (the "Company"), and Douglas E. Williams (the "Executive"). WHEREAS, the Company...Severance Agreement • March 8th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Washington
Exhibit 10.1 *Certain confidential information contained in this document, marked by brackets, has been omitted and filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. SUPPLY TRANSFER...Supply Transfer Agreement • August 14th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Maryland
EXHIBIT 10.3 AGENCY AGREEMENTAgency Agreement • March 5th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
SECOND & SENECA BUILDING SEATTLE, WASHINGTON 98101 LEASE AGREEMENT BETWEEN SECOND AND SENECA LIMITED PARTNERSHIP, a Washington Limited Partnership LANDLORD and IMMUNEX CORPORATION TENANTLease Agreement • March 18th, 1997 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
2. Term of Agreement. The Term of this Agreement shall commence on the ----------------- date hereof and shall continue in effect through December 31, 2004; provided, -------- however, that commencing on January 1, 2002 and each January 1 thereafter,...Severance Agreement • March 8th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • Washington
April 29, 2002 Board of Directors Immunex Corporation 51 University Street Seattle, WA 98101 Members of the Board of Directors: Immunex Corporation (the "Company"), Amgen Inc. (the "Acquiror") and AMS Acquisition Inc., a wholly owned subsidiary of the...Immunex Corp /De/ • April 30th, 2002 • Biological products, (no disgnostic substances)
Exhibit 10.15 AMENDMENT NO. 1 TO THE PRODUCT RIGHTS AGREEMENT This Amendment No. 1 ("Amendment No. 1") is made this 20th day of May, 1999 (the "Amendment Effective Date") by and between AMERICAN HOME PRODUCTS CORPORATION, a corporation organized and...Product Rights Agreement • March 7th, 2000 • Immunex Corp /De/ • Biological products, (no disgnostic substances)
Exhibit 10.2 * Certain confidential information contained in this document, marked by brackets, has been omitted and filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. The omitted portions...Collaboration and Global Supply Agreement • November 13th, 2001 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New Jersey
Exhibit 10.1 [AHP Letterhead] April 19, 2001 Ms. Peggy Phillips Chief Operating Officer Immunex Corporation 51 University Street Seattle, WA 98101 Re: Amendment No. 1 to Memorandum of Understanding -----------------------------------------------...Immunex Corp /De/ • May 11th, 2001 • Biological products, (no disgnostic substances)
2. New Definitions. Section 1.66 of the Agreement shall be amended to add the following new definitions: Section "Accepted Subsequent Additional Runs" 24.1(d)(2) "Adjusted Annual Minimum" 5.10(c) "Annual Minimum" 5.10(b) "Attempted Original Additional...Immunex Corp /De/ • August 11th, 2000 • Biological products, (no disgnostic substances)
Exhibit 10.2 August 9, 2000 American Home Products Corporation Five Giralda Farms Madison, NJ 07940 Attention: Kenneth J. Martin Senior Vice President and Chief Financial Officer MEMORANDUM OF UNDERSTANDING --------------------------- FOR HELIX...Immunex Corp /De/ • August 30th, 2000 • Biological products, (no disgnostic substances)
EXHIBIT 10.1 PRODUCT RIGHTS AGREEMENTProduct Rights Agreement • July 1st, 1998 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New Jersey
